Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy
Tsuyoshi Takeda, Takashi Sasaki, Chisaki Suzumori, et al.
International Journal of Clinical Oncology (2021) Vol. 26, Iss. 7, pp. 1293-1303
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Association between preoperative sarcopenia and prognosis of pancreatic cancer after curative-intent surgery: a updated systematic review and meta-analysis
Chenming Liu, Liang An, Siyuan Zhang, et al.
World Journal of Surgical Oncology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Computed Tomography-Based Sarcopenia and Pancreatic Cancer Survival—A Comprehensive Meta-Analysis Exploring the Influence of Definition Criteria, Prevalence, and Treatment Intention
Antonio Jesús Láinez Ramos‐Bossini, Antonio Martínez, David Luengo Gómez, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 607-607
Open Access | Times Cited: 2
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Anne‐Laure Couderc, Évelyne Liuu, Pascaline Boudou‐Rouquette, et al.
Nutrients (2023) Vol. 15, Iss. 5, pp. 1193-1193
Open Access | Times Cited: 28
Cancer cachexia: biomarkers and the influence of age
Julia Geppert, Maria Rohm
Molecular Oncology (2024)
Open Access | Times Cited: 6
Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis
Maximilian Thormann, Mattes Hinnerichs, Felix Barajas Ordonez, et al.
Academic Radiology (2022) Vol. 30, Iss. 8, pp. 1552-1561
Open Access | Times Cited: 25
Joint association of systemic inflammatory response index and sarcopenia with mortality among individuals with self-reported cancer
Zhifei Huang, Wenjia Peng, Mengdie Zhao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Low Muscle Mass and Treatment Tolerance in Patients With Upper Gastrointestinal Cancer: A Systematic Review and Meta‐Analysis
Edward Stanhope, Simon Nørskov Thomsen, James Turner, et al.
Deleted Journal (2025) Vol. 8, Iss. 1
Open Access
Frailty is associated with poor prognosis after resection for pancreatic cancer
Kosuke Mima, Hiromitsu Hayashi, Shigeki Nakagawa, et al.
International Journal of Clinical Oncology (2021) Vol. 26, Iss. 10, pp. 1938-1946
Closed Access | Times Cited: 31
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan
Junji Furuse, Fumihiko Osugi, Koji Machii, et al.
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 4, pp. 456-463
Open Access | Times Cited: 4
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma
Jennifer B. Permuth, Margaret Park, Evan Davis, et al.
Research Square (Research Square) (2025)
Closed Access
Sarcopenia among older patients with cancer: A scoping review of the literature
Qian Sun, Xiaohan Jiang, Rui Qin, et al.
Journal of Geriatric Oncology (2022) Vol. 13, Iss. 7, pp. 924-934
Closed Access | Times Cited: 18
Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
Yukari Suzuki, Kei Saito, Yousuke Nakai, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 3
Open Access | Times Cited: 10
Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal Adenocarcinoma
Tomoki Sugimoto, Yoshifumi Iwagami, Shogo Kobayashi, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 6, pp. 3718-3736
Closed Access | Times Cited: 3
Frailty and surgical outcomes in gastrointestinal cancer: Integration of geriatric assessment and prehabilitation into surgical practice for vulnerable patients
Kosuke Mima, Shigeki Nakagawa, Tatsunori Miyata, et al.
Annals of Gastroenterological Surgery (2022) Vol. 7, Iss. 1, pp. 27-41
Open Access | Times Cited: 15
Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia
Tsuyoshi Takeda, Takashi Sasaki, Takeshi Okamoto, et al.
Internal Medicine (2022) Vol. 62, Iss. 13, pp. 1887-1893
Open Access | Times Cited: 15
The impact of nutritional status on pancreatic cancer therapy
Gabriele Capurso, Nicolò Pecorelli, Alice Burini, et al.
Expert Review of Anticancer Therapy (2022) Vol. 22, Iss. 2, pp. 155-167
Closed Access | Times Cited: 12
RETRACTED: The impact of sarcopenia on prognosis of patients with pancreatic cancer: A systematic review and meta-analysis
Hui Gan, Jiarong Lan, Hongxia Bei, et al.
Scottish Medical Journal (2023) Vol. 68, Iss. 4, pp. 133-148
Closed Access | Times Cited: 6
Frailty Assessed by the Clinical Frailty Scale is Associated with Prognosis After Esophagectomy
Atsushi Morito, Kazuto Harada, Masaaki Iwatsuki, et al.
Annals of Surgical Oncology (2023) Vol. 30, Iss. 6, pp. 3725-3732
Closed Access | Times Cited: 5
Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer
Teruhisa Sakamoto, Masahiro Makinoya, Teppei Sunaguchi, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0271073-e0271073
Open Access | Times Cited: 8
Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology
M. Guillot Morales, Laura Visa, Elena Vázquez, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1570-1583
Open Access | Times Cited: 1
Pancreatic cancer and sarcopenia: a narrative review of the current status
Mariko Tsukagoshi, Kenichiro Araki, Ken Shirabe
International Journal of Clinical Oncology (2024) Vol. 29, Iss. 8, pp. 1055-1066
Closed Access | Times Cited: 1
Impact of baseline body composition on prognostic outcomes in urological malignancies treated with immunotherapy: a pooled analysis of 10 retrospective studies
Wangbin Ma, Shi Qiao, Lilong Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Evaluating the role of sarcopenia and [18F]FDG PET/CT parameters in prognosis of pancreatic ductal adenocarcinoma
Hasan Önner, Merve Nida Calderon Tobar, L. Perktaş, et al.
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) (2024) Vol. 43, Iss. 6, pp. 500046-500046
Closed Access | Times Cited: 1
Impact of Cachexia on Chemotherapy Efficacy and Survival in Pancreatic Cancer: A Systematic Review and Meta-Analysis
Mohamed A. Khalil, Syed Ahsan Ali Jafri, M Naqvi, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 1
Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review
Stefania Rizzo, Isabel Scala, Ángela Rodríguez Robayo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top